Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Keywords

ChemistryTriazoleReceptorLipolysisSelectivity123-TriazoleED50Chemical synthesisPharmacologyStereochemistryIn vitroAdrenergic receptorEC50AgonistAdrenergicBiochemistryOrganic chemistry

Affiliated Institutions

Merck & Co., Inc., Rahway, NJ, USA (United States) US

Related Publications

Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT1D Receptor Ligands with Improved Pharmacokinetic Profiles

Monique B. van Niel , Ian Collins , Margaret S. Beer +18 more

It has previously been reported that a 3-(3-(piperazin-1-yl)propyl)indole series of 5-HT1D receptor ligands have pharmacokinetic advantages over the corresponding 3-(3-(piperidi...

1999 Journal of Medicinal Chemistry 156 citations

Synthesis, Structure-Activity Relationships, and Pharmacological Evaluation of a Series of Fluorinated 3-Benzyl-5-Indolecarboxamides: Identification of 4-[[5-[((2R)-2-Methyl-4,4,4-trifluorobutyl)carbamoyl]-1-methylindol-3-yl]methyl]-3methoxy-N-[(2-methylphenyl)sulfonyl]benzamide, a Potent, Orally Active Antagonist of Leukotrienes D4 and E4

Robert T. Jacobs , Peter R Bernstein , Laura A. Cronk +5 more

The continued exploration of a series of 3-(arylmethyl)-1H-indole-5-carboxamides by the introduction of fluorinated amide substituents has resulted in the discovery of 4-[[5-[((...

1994 Journal of Medicinal Chemistry 40 citations

An Integrated in Silico 3D Model-Driven Discovery of a Novel, Potent, and Selective Amidosulfonamide 5-HT1A Agonist (PRX-00023) for the Treatment of Anxiety and Depression

Oren M. Becker , Dale Dhanoa , Yael Marantz +10 more

We report the discovery of a novel, potent, and selective amidosulfonamide nonazapirone 5-HT1A agonist for the treatment of anxiety and depression, which is now in Phase III cli...

2006 Journal of Medicinal Chemistry 139 citations

3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as High Affinity, Selective, and Orally Bioavailable h5-HT2A Receptor Antagonists

Michael Rowley , David J. Hallett , Simon Goodacre +13 more

The development of very high affinity, selective, and bioavailable h5-HT(2A) receptor antagonists is described. By investigation of the optimal position for the basic nitrogen i...

2001 Journal of Medicinal Chemistry 108 citations

Publication Info

Year: 2000
Type: article
Volume: 10
Issue: 18
Pages: 2111-2114
Citations: 197
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

197

OpenAlex

Cite This

APA Style

                            
                                
                                    Linda Brockunier, 
                                
                                    Emma R. Parmee, 
                                
                                    Hyun Ok
                                
                                et al.
                            
                            (2000). 
                            Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides. 
                            Bioorganic & Medicinal Chemistry Letters
                            , 10
                            (18)
                            , 2111-2114.
                            https://doi.org/10.1016/s0960-894x(00)00422-4
                        

Identifiers

DOI: 10.1016/s0960-894x(00)00422-4

Human β3-adrenergic receptor agonists containing 1,2,3-triazole-substituted benzenesulfonamides

Keywords

Affiliated Institutions

Related Publications

Fluorination of 3-(3-(Piperidin-1-yl)propyl)indoles and 3-(3-(Piperazin-1-yl)propyl)indoles Gives Selective Human 5-HT<sub>1D</sub> Receptor Ligands with Improved Pharmacokinetic Profiles

An Integrated in Silico 3D Model-Driven Discovery of a Novel, Potent, and Selective Amidosulfonamide 5-HT<sub>1A</sub> Agonist (PRX-00023) for the Treatment of Anxiety and Depression

3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as High Affinity, Selective, and Orally Bioavailable h5-HT<sub>2A</sub> Receptor Antagonists

Publication Info

External Links

Social Impact

Citation Metrics

Cite This

Identifiers